Text Size
Smaller
Bigger
Methadone

UK Researchers Say Methadone and Buprenorphine Reduce Mortality by 85%

posted 12:14 AM EST, Wed November 03, 2010
-- filed under: |

Opiate users involved in opiate substitution programs (methadone or buprenorphine) for longer than 12 months are 85% less likely to die in any given period than opiate users not involved in such treatment programs.

Researchers in Bristol and London compared the mortality rates of opiate users involved in an opiate substitution program (using methadone or buprenorphine) with the mortality rates of opiate users not involved in a treatment program.

They found that:

  • People who stayed involved in an opiate treatment program for 12 months or longer were 85% less likely to die in any given period than opiate users not involved in a treatment program
  • During a period of opiate substitution treatment, the most risky periods are the first few weeks of treatment and the first month after the end of treatment. During the first few weeks, the rate of death was almost 3 times higher than during the rest of the treatment period. In the month immediately after the end of treatment, the death rate was 8 or 9 times the rate observed during the period of stable treatment.

The full research results on opiate substitution program mortality can be read in BMJ.

Email It Send this page Print It Print friendly page Subscribe Subscribe to this topic category
Story Highlights
  • Methadone and Buprenorphine: People who get involved in an opiate substitution program for longer than 12 months greatly reduce their odds of early death.
Creative Commons License
Copyright Notice
We welcome republishing of our content on condition that you credit Choose Help and the respective authors. This article is licensed under a Creative Commons License.

Join Thousands of Readers

who receive our weekly recovery newsletter.

Call Now for
Rehab Options
Insurance Accepted
(Except Medicare)
Helpful Information
Comparing Zubsolv with Suboxone
Zubsolv vs. Suboxone: Similarities and Differences © Or Hiltch
Zubsolv is a new drug for opiate dependence. Like Suboxone, it’s composed of a combination of buprenorphine and naloxone. Read on to learn about how it works and how it differs from Suboxone. Read Article
Drug Rehab December 17, 2013 (117)
Getting High on Suboxone?
Getting High on Suboxone? The FDA Says It's Happening - Ex NIDA Director Blames Doctors © Supertheman
Users taking Suboxone to stave off the withdrawal pains of an opiate addiction aren't supposed to be able to abuse the medication. That was the idea anyway when the FDA approved the drug in 2002 for take-home use. Today's thriving street market for the drug has the FDA change its tune. Read Article
Addiction Treatment February 24, 2008 (128)
8 Lies about Methadone Exposed
8 Methadone Falsehoods – Forget the Fiction, Learn the Facts © Hkoppdelaney
Think you know methadone? Be careful, because a lot of what’s passed as common knowledge about this controversial medication has little basis in fact. Here are 8 common methadone myths exposed and debunked. Read Article
Suboxone & Methadone September 06, 2011 (53)
Like Our Site? Follow Us!

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.